Global Exporter & Bulk Supplier: Erlolieva 150mg Tablet

🌍 Market Overview

Are you searching for a highly dependable international supply chain partner for advanced targeted oncology therapeutics?

Ernest Oncology (a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd.) operates as a premier global exporter, bulk supplier, and distributor of Erlolieva 150mg Tablets. Utilizing a fully compliant, professional pharmaceutical logistics framework, we manage efficient, high-capacity export operations to deliver premium Erlotinib 150mg directly to hospital networks, specialty clinics, pharmacy chains, and international medicine wholesale groups across the USA, UK, Australia, and South Africa. 

🔬 Product Profile: Erlolieva 150mg Tablet

Erlolieva 150mg contains Erlotinib, a potent, oral, highly selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI). It works at the cellular level by blocking the intracellular phosphorylation of tyrosine kinase associated with the EGFR, effectively halting the cell signaling pathways that trigger the proliferation and survival of malignant cells.

• Active Ingredient: Erlotinib (150mg)

• Therapeutic Class: Antineoplastic / Epidermal Growth Factor Receptor (EGFR) Kinase Inhibitor

• Primary Indications: * Non-Small Cell Lung Cancer (NSCLC): Treatment of patients with metastatic non-small cell lung cancer whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations.

  • Pancreatic Cancer: Formulated in combination with gemcitabine for the first-line treatment of patients with locally advanced, unresectable, or metastatic pancreatic cancer.

📦 Logistics & Sourcing Capabilities

• Compliant Supply Lines: Sourced directly through strictly validated pharmaceutical channels operating in total alignment with international GMP compliance protocols.

• Streamlined Global Export: Specialized logistics pathways custom-engineered to seamlessly manage strict customs entry protocols, documentation, and regulatory clearances inside the USA, UK, Australia, and South Africa.

• Institutional Sourcing Power: Fully capable of supporting consistent, high-volume contract wholesale fulfillments for healthcare ministries, clinical groups, and international pharmaceutical networks.

• B2B Documentation Suite: Delivery of full documentation portfolios including validated Certificates of Analysis (COA), export invoices, and batch traceability sheets.

PRESCRIPTION MEDICINE IS :YES

⚠️Disclaimer

Erlolieva 150mg Tablet is a high-potency, targeted prescription antineoplastic medication. It must be administered strictly under the direct guidance, prescription, and supervision of a registered medical oncologist or specialized healthcare physician. The information listed here is compiled exclusively for B2B procurement, wholesale trade, and commercial pharmaceutical distribution networks; it does not serve as a substitute for professional patient-centric medical advice

📞 Contact Ernest Oncology — Global Medicine Exporter

[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]

🌐 Websites:

• www.oncologymedicinesupplier.com

• www.ernestpharmaceuticals.com

• www.ernestimpex.com

• www.ernestvision.com

📧 Email: exports@ernestpharmaceuticals.com

📦 Business Type: Exporter | Bulk Supplier | Distributor

📲 WhatsApp: +91 93599 02383

🔗 WhatsApp Direct Link:https://wa.me/919359902383